Héctor Armengod
Latham & Watkins LLP
Articles
Merger Control in Europe Following COVID-19
European Union - March 24 2020 Whereas COVID-19 is likely to delay review timelines of many M&A deals, it may also make some approvals easier…
Jacques-Philippe Gunther, Jonathan Parker, Luca Crocco, Michael J. Esser, Sebastian Max Hauser, Sven B. Völcker.
Deal Planning After Brexit — Merger Control Aspects
European Union, United Kingdom - January 29 2020 On 23 January 2020, the UK passed legislation to leave the EU on 31 January 2020 under the terms of the Withdrawal Agreement negotiated with the EU…
David Little, Greg Bonné, John D. Colahan, Jonathan Parker, Luca Crocco, Nathan Wilkins, Sven B. Völcker.
Time to Prepare for New EU Medical Device Regime
European Union, United Kingdom - May 24 2019 On 26 May 2020, Regulation (EU) 2017/745 on medical devices (MDR) will become fully active, reflecting an overhaul of the current regulatory framework…
Christoph W.G. Engeler, Frances Stocks Allen, Gail E. Crawford, Henrietta J. Ditzen, Oliver Mobasser, Robbie McLaren.
MHRA Releases No-Deal Brexit Guidance for Life Sciences Companies
European Union, United Kingdom - April 4 2019 The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published a significant volume of guidance documents on various aspects of the…
Christoph W.G. Engeler, Frances Stocks Allen, Gail E. Crawford, Henrietta J. Ditzen, Oliver Mobasser, Robbie McLaren.
European Commission Proposes Framework to Screen Certain Foreign Direct Investments
European Union - September 22 2017 Proposal coordinates existing national screening mechanisms, grants the Commission powers to review investments of "Union interest." European…
